http://www.fatetherapeutics.com
Fate Therapeutics, Inc. Company Intro
for immuno-oncology [CD34+] for immuno-regulation [T-Cell, NK Cell]
Industry
Healthcare
Fate Therapeutics, Inc. Headquaters
3535 General Atomics Court
San Diego,92121
United States
Fate Therapeutics, Inc. Share price
22 Apr 2021 01:39 GMT
$77.10
-1.08 (-1.38 %)
Fate Therapeutics, Inc. Market cap
$7.9 B
WMC RANKING
2021
Fate Therapeutics, Inc. # 146
BiotechnologyLatest Fate Therapeutics, Inc. News
16 Apr 2021
Induced Pluripotent Stem Cells (iPSCs) Market Report ...
Leading Company for Driving Market Growth ... Fate Therapeutics, Inc ... Global Market Monitor is a professional modern consulting company, engaged in three ...
16 Apr 2021
We're Interested To See How Fate Therapeutics (NASDAQ ...
A company's cash runway is the amount of time it would take to burn through its cash reserves at its current cash burn rate. In December 2020, Fate Therapeutics ...
16 Apr 2021
Corbus Pharmaceuticals Holdings Inc. stock falls Friday ...
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Fate Therapeutics Inc. FATE, -3.83% fell 3.83% to $81.17, ...
WMC Market Score
WMC Market to Revenue Score
Fate Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Fate Therapeutics, Inc. | USD | $18,340 | $142,104 | $-148,578 | $79,000B | 146 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $542,600B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,205,683 | $2,599,993 | $2,711,647 | $568,780B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,069,900 | $2,656,500 | $603,400 | $367,910B | 3 |
| Incyte Corporation | USD | $2,229,409 | $1,622,822 | $446,906 | $186,280B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Fate Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Fate Therapeutics, Inc. Post vs Top 4 Industry Competitors
Fate Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Fate Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Fate Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Fate Therapeutics, Inc. | 0.20 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 23.95 | 7.31 | 100 | 0 | 0 | 50.46 |
| Vertex Pharmaceuticals Incorporated | 67.14 | 35.08 | 2.43 | 86 | 0 | 0 | 47.42 |
| Alexion Pharmaceuticals, Inc. | 65.67 | 100 | 100 | 60 | 0 | 0 | 100 |
| Incyte Corporation | 24.12 | 4.95 | 0.18 | 2 | 0 | 0 | 2.90 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
